Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys.

Kempen HJ, Gomaraschi M, Bellibas SE, Plassmann S, Zerler B, Collins HL, Adelman SJ, Calabresi L, Wijngaard PL.

J Lipid Res. 2013 Sep;54(9):2341-53. doi: 10.1194/jlr.M033779. Epub 2013 Jul 4.

2.

High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.

Kempen HJ, Asztalos BF, Moerland M, Jeyarajah E, Otvos J, Kallend DG, Bellibas SE, Wijngaard PL.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):736-42. doi: 10.1161/ATVBAHA.115.307052. Epub 2016 Feb 25.

3.

5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.

Amar MJ, D'Souza W, Turner S, Demosky S, Sviridov D, Stonik J, Luchoomun J, Voogt J, Hellerstein M, Sviridov D, Remaley AT.

J Pharmacol Exp Ther. 2010 Aug;334(2):634-41. doi: 10.1124/jpet.110.167890. Epub 2010 May 19.

4.

Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients.

Kempen HJ, Gomaraschi M, Simonelli S, Calabresi L, Moerland M, Otvos J, Jeyarajah E, Kallend D, Wijngaard PLJ.

Atherosclerosis. 2016 Dec;255:17-24. doi: 10.1016/j.atherosclerosis.2016.10.042. Epub 2016 Oct 24.

PMID:
27816804
5.

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size.

Kempen HJ, Schranz DB, Asztalos BF, Otvos J, Jeyarajah E, Drazul-Schrader D, Collins HL, Adelman SJ, Wijngaard PL.

J Lipids. 2014;2014:923903. doi: 10.1155/2014/923903. Epub 2014 Nov 12.

6.

Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.

Thorngate FE, Yancey PG, Kellner-Weibel G, Rudel LL, Rothblat GH, Williams DL.

J Lipid Res. 2003 Dec;44(12):2331-8. Epub 2003 Sep 1.

8.

Effect of lecithin:cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma.

Bisgaier CL, Sachdev OP, Lee ES, Williams KJ, Blum CB, Glickman RM.

J Lipid Res. 1987 Jun;28(6):693-703.

9.

Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.

Lee M, Calabresi L, Chiesa G, Franceschini G, Kovanen PT.

Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1475-81.

10.

In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux.

Yancey PG, Kawashiri MA, Moore R, Glick JM, Williams DL, Connelly MA, Rader DJ, Rothblat GH.

J Lipid Res. 2004 Feb;45(2):337-46. Epub 2003 Nov 1.

11.

Influence of dietary lipids on hepatic mRNA levels of proteins regulating plasma lipoproteins in baboons with high and low levels of large high density lipoproteins.

Kushwaha RS, McMahan CA, Mott GE, Carey KD, Reardon CA, Getz GS, McGill HC Jr.

J Lipid Res. 1991 Dec;32(12):1929-40.

12.
14.

Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans.

Nanjee MN, Cooke CJ, Garvin R, Semeria F, Lewis G, Olszewski WL, Miller NE.

J Lipid Res. 2001 Oct;42(10):1586-93.

15.

Characterization of lipoprotein produced by the perfused rhesus monkey liver.

Jones LA, Teramoto T, Juhn DJ, Goldberg RB, Rubenstein AH, Getz GS.

J Lipid Res. 1984 Apr;25(4):319-35.

16.
17.

The Effect of Natural LCAT Mutations on the Biogenesis of HDL.

Fotakis P, Kuivenhoven JA, Dafnis E, Kardassis D, Zannis VI.

Biochemistry. 2015 Jun 2;54(21):3348-59. doi: 10.1021/acs.biochem.5b00180. Epub 2015 May 22.

PMID:
25948084
18.
19.

Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I-, and apolipoprotein E-deficient mice.

Huang Y, Zhu Y, Langer C, Raabe M, Wu S, Wiesenhütter B, Seedorf U, Maeda N, Assmann G, von Eckardstein A.

Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2010-9.

20.

Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux.

Gillotte KL, Davidson WS, Lund-Katz S, Rothblat GH, Phillips MC.

J Biol Chem. 1996 Sep 27;271(39):23792-8.

Supplemental Content

Support Center